JP2023522512A5 - - Google Patents

Info

Publication number
JP2023522512A5
JP2023522512A5 JP2022528946A JP2022528946A JP2023522512A5 JP 2023522512 A5 JP2023522512 A5 JP 2023522512A5 JP 2022528946 A JP2022528946 A JP 2022528946A JP 2022528946 A JP2022528946 A JP 2022528946A JP 2023522512 A5 JP2023522512 A5 JP 2023522512A5
Authority
JP
Japan
Prior art keywords
cells
common
neoepitope
mutant peptide
identified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528946A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522512A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/061009 external-priority patent/WO2021101962A1/en
Publication of JP2023522512A publication Critical patent/JP2023522512A/ja
Publication of JP2023522512A5 publication Critical patent/JP2023522512A5/ja
Pending legal-status Critical Current

Links

JP2022528946A 2019-11-18 2020-11-18 共通のネオエピトープワクチンのための改善された組成物及び方法 Pending JP2023522512A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962936654P 2019-11-18 2019-11-18
US62/936,654 2019-11-18
US202062959440P 2020-01-10 2020-01-10
US62/959,440 2020-01-10
US202062982173P 2020-02-27 2020-02-27
US62/982,173 2020-02-27
PCT/US2020/061009 WO2021101962A1 (en) 2019-11-18 2020-11-18 Improved compositions and methods for shared neo-epitope vaccines

Publications (2)

Publication Number Publication Date
JP2023522512A JP2023522512A (ja) 2023-05-31
JP2023522512A5 true JP2023522512A5 (enExample) 2023-11-29

Family

ID=73835748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528946A Pending JP2023522512A (ja) 2019-11-18 2020-11-18 共通のネオエピトープワクチンのための改善された組成物及び方法

Country Status (5)

Country Link
US (2) US20210145951A1 (enExample)
EP (1) EP4062177A1 (enExample)
JP (1) JP2023522512A (enExample)
CA (1) CA3158646A1 (enExample)
WO (1) WO2021101962A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202144388A (zh) 2020-02-14 2021-12-01 美商健生生物科技公司 在卵巢癌中表現之新抗原及其用途
CN119462833A (zh) * 2023-11-21 2025-02-18 上海市第一人民医院 肿瘤抗原肽及其用途
US20250197924A1 (en) * 2023-12-15 2025-06-19 Amazon Technologies, Inc. Methods for selection and combination of sequencing results from biological samples for neoantigen scoring

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3323070B1 (en) * 2015-07-14 2024-05-08 Personal Genome Diagnostics Inc. Neoantigen analysis
JP2019512263A (ja) * 2016-02-22 2019-05-16 オーシャンサイド バイオテクノロジー 免疫療法におけるネオ抗原組成物及び同組成物を使用する方法
WO2019036043A2 (en) * 2017-08-16 2019-02-21 Medgenome Inc. METHOD FOR GENERATING A COCKTAIL OF PERSONALIZED ANTICANCER VACCINES FROM TUMOR DERIVED GENETIC MODIFICATIONS FOR THE TREATMENT OF CANCER
AU2019275072A1 (en) * 2018-05-23 2021-01-21 Seattle Project Corp. Shared antigens

Similar Documents

Publication Publication Date Title
JP7592060B2 (ja) 免疫原性変異体ペプチドスクリーニングプラットフォーム
US12404490B2 (en) AGGF1 immunogenic compositions
JP7082051B2 (ja) 抗原特異的ｃｄ８＋ｔ細胞の産生におけるインターロイキン－１０及びその使用方法
JP2018530579A (ja) ウイルス性癌ネオエピトープのための組成物および方法
JP2023522512A5 (enExample)
Tang et al. A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction
BR112019021094A2 (pt) Peptídeos e combinações dos mesmos para uso na imunoterapia contra leucemias e outros cânceres
EP4361267A1 (en) Method for identifying t-cell epitope sequence, and application of same
JP2022533861A5 (enExample)
CN113272419A (zh) 制备治疗性t淋巴细胞的方法
EP4311834A1 (en) Peptides and combinations of peptides for use in immunotherapy against ropharyngeal squamous cell carcinoma (opscc) and other cancers
HK40074082A (en) Immunogenic mutant peptide screening platform
HK1242779A1 (en) Immunogenic mutant peptide screening platform
HK1242779B (zh) 免疫原性突变体肽筛选平台